Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Study of ACVBP Plus Rituximab Versus CHOP Plus Rituximab in Non Previously Treated Patients Aged From 60 to 65 Years With Diffuse Large B-Cell Lymphoma

NCT00135499 is registered in ClinicalTrials.gov with Lymphoma Study Association as lead sponsor.

NCT NCT00135499
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00135499 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Study of ACVBP Plus Rituximab Versus CHOP Plus Rituximab in Non Previously Treated Patients Aged From 60 to 65 Years With Diffuse Large B-Cell Lymphoma
Lead sponsor
Lymphoma Study Association
Phase
Phase 3
Overall status
Terminated
Start date
October 16, 2001
Completion date
April 27, 2010
Enrollment
138 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma, large-cell, diffuse